null

Hu9F2 (Anti-GPC3) Biosimilar Antibody

SKU:
HDBS0125
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
GPC3
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Hu9F2 (Anti-GPC3) Biosimilar Antibody (HDBS0125)

The Hu9F2 Biosimilar Anti-GPC3 Antibody is a novel therapeutic antibody designed for targeting GPC3 (Glypican 3), a cell surface protein that is highly expressed in certain cancer cells. This biosimilar antibody, derived from a humanized monoclonal antibody, has been specifically engineered to bind to GPC3 with high affinity, effectively blocking its function and inhibiting cancer cell growth.This antibody has shown promising results in preclinical studies, demonstrating potent anti-tumor activity against GPC3-expressing cancer cells.

Its unique design and mechanism of action make it a valuable tool for cancer research and potential therapeutic development.The Hu9F2 Biosimilar Anti-GPC3 Antibody is a cutting-edge product that holds great potential for the treatment of GPC3-positive cancers, including hepatocellular carcinoma and certain pediatric solid tumors. Its specificity and efficacy make it a valuable asset for researchers and clinicians working towards improving outcomes for patients with these challenging diseases.